Ecolab (ECL) Earnings Date & Reports

Key Takeaways

• Adjusted diluted earnings per share (EPS) rose 5% year over year to $2.18, matching analyst consensus estimates.
• Revenue climbed 13% year over year to $4.69 billion, slightly ahead of consensus, while organic sales grew 7%.
• Reported (GAAP) diluted EPS was $1.95, down 5% from the prior-year quarter, reflecting acquisition-related costs.
• Organic operating income margin expanded 70 basis points (bps) to 19.6%, keeping Ecolab on track toward its 20% margin target for 2027.
• Full-year 2026 adjusted EPS guidance was narrowed to $8.10–$8.20, and fourth-quarter adjusted EPS guidance was set at $2.13–$2.23.
• For more detail on Ecolab's Major News, Today's Price Move, Price Targets, and Forecast, explore these dedicated pages for the latest insights.
• Discover automated trading strategies and market opportunities with Trending AI Robots.

Earnings Context and Why It Matters

Ecolab's quarterly results offer a read on broad industrial and commercial demand, given the company's reach across water treatment, hygiene, cleaning, and infection prevention for customers in food, healthcare, hospitality, and manufacturing. The third-quarter report is especially significant because it shows whether Ecolab's growth engines — Global High-Tech, Life Sciences, Pest Elimination, and digital solutions — can sustain momentum while rising commodity costs and geopolitical disruptions, including customer interruptions in the Middle East, pressure the broader operating environment. With management pursuing a 20% adjusted operating margin target by 2027, investors are watching closely whether pricing gains and productivity improvements can offset cost inflation and the early integration effects of recent acquisitions such as Ovivo Electronics and CoolIT.

Reported Results

For the third quarter ended September 30, 2026, Ecolab reported adjusted diluted EPS of $2.18, up 5% from $2.08 a year earlier and in line with the consensus estimate. Reported (GAAP) diluted EPS was $1.95, down 5% from $2.05 in the prior-year period, reflecting special gains and charges tied primarily to acquisition and integration costs.

Net sales rose 13% year over year to $4.69 billion, slightly ahead of the Zacks consensus estimate of $4.67 billion. Organic sales increased 7%, driven by a 5% contribution from pricing and a 2% increase in volume. Ecolab Digital sales jumped 34% to $129 million, while Global Life Sciences delivered 17% organic sales growth on continued share gains in bioprocessing, personal care, and purification.

Reported gross margin contracted 70 bps to 44.1%, largely due to acquisition mix, while organic gross margin improved 10 bps to 44.9% as pricing offset higher commodity costs. Adjusted operating income rose 13.6% to $893.4 million, and organic operating income margin expanded 70 bps to 19.6%.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery tool designed to help traders and investors filter the market more efficiently. It allows users to scan thousands of stocks and exchange-traded funds (ETFs) using customizable criteria such as industry, market capitalization, technical indicators, price patterns, and performance metrics. By combining technical patterns, fundamentals, trends, volatility, and AI-driven signals, the screener helps surface trade ideas, trending stocks, and breakout candidates without the need for time-consuming manual screening. For investors monitoring names like Ecolab and the broader specialty chemicals sector, the AI Screener offers a practical way to identify new opportunities and refine watchlists.

Market Reaction and Investor Sentiment

Ecolab shares closed at $288.89 on October 27, 2026, with the stock up roughly 4% over the prior three months and nearly 8% over the trailing 12 months. The in-line EPS result and modest revenue beat did not produce a dramatic post-earnings swing, suggesting investors had already priced in steady execution. The narrowed full-year guidance — a range of $8.10 to $8.20 versus a prior $8.05 to $8.25 — reinforced confidence in the company's trajectory without a major upside surprise. Sentiment remains supported by accelerating organic sales growth and broad-based margin expansion, though acquisition-related amortization and financing costs from the CoolIT deal continue to weigh on near-term adjusted EPS growth.

Forward Outlook and Key Factors to Monitor

Looking ahead, Ecolab guided to fourth-quarter 2026 reported sales growth of 12% to 14%, organic sales growth of 6% to 7%, and adjusted diluted EPS of $2.13 to $2.23. For the full year, management narrowed its adjusted EPS outlook to $8.10–$8.20, reflecting 8% to 9% growth versus 2025 despite an approximate six-percentage-point headwind from CoolIT acquisition-related amortization and financing costs.

Investors should monitor several factors in the coming quarters. First, whether pricing power can continue to offset rising commodity costs and whether organic gross margin holds near 44.9%. Second, the pace of integration for the Ovivo Electronics and CoolIT acquisitions, which have diluted reported margins but are expected to strengthen long-term growth. Third, demand signals in Global High-Tech and Life Sciences, which have been standout performers tied to microelectronics, data centers, and bioprocessing.

Finally, watch progress toward the 20% adjusted operating margin target for 2027, with management citing continued pricing execution, productivity gains, and a favorable mix shift toward higher-margin digital and life-sciences offerings as key drivers.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations